Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleWhy we should not recommend or offer fluvoxamine to COVID-19 patients?AuthorsTrkulja, VladimirSubjectsDISEASE progression; DRUG efficacy; COVID-19; HOSPITAL emergency services; FLUVOXAMINE; TREATMENT effectiveness; HOSPITAL carePublicationEuropean Journal of Clinical Pharmacology, 2023, Vol 79, Issue 2, p321ISSN0031-6970Publication typeLetter to the EditorDOI10.1007/s00228-022-03447-3